Related Experiment Video
Updated: May 18, 2026
06:11
Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
Head and neck cancer in the elderly population
Farzan Siddiqui1, Clement K Gwede
1Department of Radiation Oncology, The James Cancer Hospital, Ohio State University, Columbus, OH 43210, USA. farzansid@gmail.com
Seminars in Radiation Oncology
|September 19, 2012
Summary
Elderly head and neck cancer (HNC) patients often have comorbidities, complicating aggressive treatments. This review discusses challenges and solutions for managing HNC in older adults, focusing on treatment tolerance and quality of life.
Area of Science:
- Oncology
- Geriatric Medicine
- Radiation Oncology
Background:
- Head and neck cancer (HNC) frequently presents at advanced stages (III-IV), necessitating multimodality treatment.
- Treatment paradigms for elderly HNC patients are not well-defined due to comorbidities and concerns about treatment tolerance.
- The elderly HNC population is increasing, posing unique management challenges.
Purpose of the Study:
- To review challenges in managing elderly HNC patients.
- To highlight complexities and toxicities of combined modality treatments in this population.
- To discuss the impact of age and comorbidity on treatment decisions, prognosis, and quality of life.
Main Methods:
- Literature review focusing on elderly HNC patients.
- Analysis of treatment selection considering age and comorbidity.
- Emphasis on radiation therapy and combined modality therapy outcomes.
- Discussion of potential interactions between age, comorbidity, and treatment toxicity.
Main Results:
- Elderly patients may be excluded from aggressive treatments due to comorbidities and frailty.
- Combined modality treatments can lead to increased complexity and toxicity in older adults.
- Age and comorbidity significantly influence treatment tolerance, prognosis, and quality of life.
Conclusions:
- Management of elderly HNC patients requires careful consideration of individual comorbidities and overall health status.
- Further research is needed to optimize treatment strategies for older adults with HNC.
- Tailoring treatment plans is crucial to balance efficacy with quality of life in elderly HNC patients.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:26Arteries of the Head and Neck
The human body's intricate network of arteries ensures that every organ system receives the necessary oxygen and nutrients for optimal function. The arterial network in the head and neck region is particularly complex, providing vital blood flow to the brain, eyes, and other critical structures. Prominent arteries in this region include the internal carotid arteries and the vertebral arteries.
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...